Breaking News
Has A Global Catastrophe Been Averted, Or Is This Just A Very Temporary Reprieve?
Blocking The Internet Archive Won't Stop AI, But It Will Erase The Web's Historical Record
Here is why Nasdaq and owner of NYSE are putting the $126 trillion equity market on blockchain
JFK: The Memo That Might Have Stopped Israel's War on Iran
Top Tech News
We Build and Test Microwave Blocking Panels - Invisible to Radar
Man Successfully Designs mRNA Vaccine To Treat His Dog's Cancer
Watch: Humanoid robot gets surprisingly good at tennis
Low-cost hypersonic rocket engine takes flight for US Air Force
Your WiFi Can See You. Here's How.
Decentralizing Defense: A $96 Guided Rocket Just Put Precision Warfare into the Hands of the People
Israel's Iron Beam and the laser future of missile defense
Scientists at the Harbin University of Science and Technology have pioneered a sophisticated...
Researchers have developed a breakthrough "molecular jackhammer" technique...
Human trials are underway for a drug that regrows human teeth in just 4 days.
Defining an Xprize for Aging Reversal and Antiaging Developments
Dr. Aubrey de Grey of SENS Research Foundation gave the keynote speech at Ending Age-Related Diseases 2020. Aubrey discussed the current state of the rejuvenation biotechnology industry and how the current pandemic is shifting medical and science priorities. He mentions the failure of Unity Biotechnology's Phase 2 clinical trial for osteoarthritis, COVID-19 and the elderly immune system, the current popularization of rejuvenation biotechnology and developments to a world without age-related diseases.
There is now funding for the detailed work to define an Aging reversal XPrize focused on rejuvenating the immune system. The detailed definition of an XPrize requires nearly $1 million. Michael Antonov and Sergey Young have provided the funding.